Vaccitech
  • Home
  • About
    • Approach
    • Our Team
  • Technology
  • Portfolio
  • Partnerships
  • Newsroom
  • Careers
  • Contact
Select Page
  • News & Updates
    Learn more
HELLO WORLD
ILLUSTRATOR
WRITER
WEB-DESIGNER

VANCE: First in Human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine

Jun 5, 2018

View/Download ASCO 2018 Poster

Recent Posts

  • VANCE: First in Human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine
  • Phase 1 Data on the Vaccitech Prostate Cancer Vaccine Presented at ASCO 2018
  • Universal Flu Vaccine Data Presented at NFID 2018
  • Flu vaccine Study Recruits First Participants
  • Vaccitech secures £20m Series A with GV, OSI and Sequoia China

Vaccitech Limited

Magdalen Centre
1 Robert Robinson Avenue
The Oxford Science Park
Oxford OX4 4GA

T: +44 01865 818808

  • Home
  • About
  • Sitemap
  • Privacy Policy
  • Privacy Notice
  • Careers
  • Contact

Vaccitech is a spin-out company from the University of Oxford’s Jenner Institute, one of the oldest and most renowned vaccine research centres in the world.

© Vaccitech 2018 All rights reserved. Website by Brand Cooke